These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19570685)

  • 21. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.
    Katzan IL; Hammer MD; Hixson ED; Furlan AJ; Abou-Chebl A; Nadzam DM;
    Arch Neurol; 2004 Mar; 61(3):346-50. PubMed ID: 15023810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
    Sobesky J; Frackowiak M; Zaro Weber O; Hahn M; Möller-Hartmann W; Rudolf J; Neveling M; Grond M; Schmulling S; Jacobs A; Heiss WD
    Cerebrovasc Dis; 2007; 24(1):56-65. PubMed ID: 17519545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intravenous thrombolysis patients with acute ischemic stroke: the analysis of the 100 cases. Part I. Characteristic of the patients and effectiveness of treatment].
    Sobolewski P; Sledzińska M; Szczuchniak W; Hatalska-Zerebiec R; Grzesik M; Sobota A
    Przegl Lek; 2012; 69(6):237-41. PubMed ID: 23094435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombolytic therapy for acute ischaemic stroke: successful implementation in an Australian tertiary hospital.
    Bray JE; Coughlan K; Bladin C
    Intern Med J; 2006 Aug; 36(8):483-8. PubMed ID: 16866650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intravenous tissue plasminogen activator in the treatment of acute ischemic stroke: feasibility, safety, and efficiency in the 2 first years of the clinical practice].
    Feuerhake W; Chamorro H; Araya F
    Rev Med Chil; 1999 Jul; 127(7):814-9. PubMed ID: 10668289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
    J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comment on "Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008".
    Sharma VK; Teoh HL; Chan BP
    J Clin Neurosci; 2010 Apr; 17(4):543-4. PubMed ID: 20167497
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment.
    Fink J
    N Z Med J; 2005 May; 118(1214):U1430. PubMed ID: 15886726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of acute nonthrombolytic and thrombolytic treatments in ischemic stroke patients 80 years or older.
    Zacharatos H; Hassan AE; Vazquez G; Hussein HM; Rodriguez GJ; Suri MF; Lakshminarayan K; Ezzeddine MA; Qureshi AI
    Am J Emerg Med; 2012 Jan; 30(1):158-64. PubMed ID: 21247724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of physiologic derangement in patients with stroke treated with thrombolysis.
    Idicula TT; Waje-Andreassen U; Brogger J; Naess H; Lundstadsveen MT; Thomassen L
    J Stroke Cerebrovasc Dis; 2008; 17(3):141-6. PubMed ID: 18436155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombolysis for acute ischemic stroke with recombinant tissue plasminogen activator in a Chilean public hospital].
    Figueroa-Reyes T; Sáez M D; Mansilla L E; Sánchez V R; Nogales-Gaete J; Delgado B I
    Rev Med Chil; 2011 Sep; 139(9):1118-27. PubMed ID: 22215389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombolytic treatment for acute ischemic stroke: a 2 year-experience at King Chulalongkorn Memorial Hospital.
    Suwanwela NC; Phanthumchinda K; Suwanwela N; Tantivatana J; Janchai A
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S428-36. PubMed ID: 11529370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry.
    Koga M; Kimura K; Shibazaki K; Shiokawa Y; Nakagawara J; Furui E; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Naganuma M; Nezu T; Maeda K; Minematsu K; Toyoda K
    J Neurol Sci; 2011 Jul; 306(1-2):49-53. PubMed ID: 21492878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does time of day or physician experience affect outcome of acute ischemic stroke patients treated with thrombolysis? A study from Finland.
    Helsinki Stroke Thrombolysis Registry Group
    Int J Stroke; 2012 Aug; 7(6):511-6. PubMed ID: 22494345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator.
    Weimar C; Kraywinkel K; Maschke M; Diener HC;
    Cerebrovasc Dis; 2006; 22(5-6):429-31. PubMed ID: 16912477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.